What’s better than good news? More good news!
While we usually try not to brag, sometimes it’s hard not to: Five of the 27 newly named Howard Hughes Medical Institute Investigators are former winners or finalists of the Vilcek Prizes for Creative Promise in Biomedical Science! A highly coveted honor, scientists appointed HHMI Investigators are provided generous, long-term flexible funding that allows them to pursue their studies without the constraints of more conventional grants.
Not only were five of our prize alumni selected, but close to half (48%) of the 2013 HHMI Investigators are foreign-born – a clear demonstration of the important role immigrant scientists play in upholding the quality of scientific research in America.
Harmit Malik, Principal Investigator, Fred Hutchinson Cancer Research Center
Vamsi Mootha, Professor, Harvard Medical School
Evgeny Nudler, Julie Wilson Anderson Professor of Biochemistry, NYU Langone Medical Center
Michael Rape, Associate Professor, University of California, Berkeley
Aviv Regev, Associate Professor, Massachusetts Institute of Technology
Please join us in congratulating our prize alumni and the rest of the HHMI Investigators by taking a moment to learn more about their research, which ranges from studies of ancient viruses to explorations of how songbirds learn to sing. If you know any promising, foreign-born biomedical scientists not more than 38 years old, or are one yourself, applications are now open for the 2014 Vilcek Prizes for Creative Promise in Biomedical Science. (And in the arts, we are accepting applications in Design!)
Announcing the 2018 Vilcek Prizewinners
Congratulations to the remarkable biomedical scientists and professionals in the architecture field who have been awarded the 2018 Vilcek Prizes. Learn more about their incredible accomplishments:
In Support of DACA
2017 was a tumultuous year for immigration policy in the United States, with several controversial restrictions issued by the new administration. As former refugees and green card holders, our founders Jan and Marica Vilcek share their thoughts on these policies.